AVELAS Trademark

Biotechnology research; oncology research; research and development in the biotechnology and oncology fields; development of new technology in the field of biotechnology to enable systemic delivery of cell-penetrating peptides (CPP) and associated cargo to cancer cells; development of new biotechnology, namely, using activatable cell-penetrating peptides (ACPPs) or other enzyme mediated mechanism for surgical and therapeutic applications for cancer patients; development of new biotechnology in the field of oncology for the purpose of delivering a fluorescent, cancer-illuminating probe to detect cancer tissue; development of new biotechnology for intraoperative tumor detection; biotechnology research in connection with developing an intravenously administered in vivo fluorescent protease-activatable peptide for the purpose of detecting, marking, targeting, and diagnosing cancer; conducting clinical trials in the field of biotechnology; clinical research in the field of oncology, namely, cancer surgery and therapeutic intervention; conducting research and clinical trials relating to activatable cell-penetrating peptides (ACPPs) and fluorescence image-guided surgery in the field of oncology; medical research services in the field of cancer

Pharmaceuticals for the treatment of cancer; pharmaceuticals for use in the fields of biotechnology and oncology; pharmaceutical products for intraoperative tumor detection, namely, an intravenously administered in vivo fluorescent protease-activatable peptide for the purpose of detecting, marking, targeting, and diagnosing cancer; pharmaceuticals, namely, activatable cell-penetrating peptides (ACPPs) and fluorescence, for the purpose of enabling image-guided surgery in the field of oncology; pharmaceutical preparations, namely, a drug delivery platform involving activatable cell-penetrating peptides (ACPPs); a drug delivery platform utilizing enzyme activation; drug delivery agents, namely, activatable cell-penetrating peptides (ACPPs) or other enzyme mediated mechanism using pathological enzymatic activity to selectively deliver imaging cargo to target tissue; pharmaceuticals to enable systemic delivery of cell-penetrating peptides (CPP) and associated cargo to cancer cells for surgical applications; pharmaceuticals preparations for fluorescence image-guided surgery